| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.30B | +6.8% |
| Cost of Revenue | $2.63B | -1.0% |
| Gross Profit | $1.67B | +22.0% |
| R&D Expense | $219.6M | +26.6% |
| SG&A Expense | $285.1M | +12.7% |
| Operating Income | $536.7M | +39.0% |
| Interest Expense | $89.7M | -8.1% |
| Pre-tax Income | $409.4M | +41.0% |
| Income Tax | $92.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $281.3M | +39.9% |
| Accounts Receivable | $612.1M | +13.9% |
| Inventory | $1.03B | -11.6% |
| Current Assets | $2.03B | +1.7% |
| Total Assets | $5.11B | +0.3% |
| Current Liabilities | $1.03B | +17.3% |
| Long-term Debt | $1.21B | -15.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $741.3M | +42.1% |
| Capital Expenditures | $136.7M | +5.9% |
| Investing Cash Flow | -$208.7M | -17.2% |
| Financing Cash Flow | -$448.8M | -62.0% |
| Free Cash Flow | $604.6M | +54.0% |
| +26.3% |
| Net Income | $316.3M | +47.4% |
| EPS (Basic) | $5.46 | +65.0% |
| EPS (Diluted) | $5.39 | +64.8% |
| Total Liabilities |
| $2.61B |
| -4.8% |
| Stockholders' Equity | $2.49B | +6.6% |